Propranolol Treatment for Infantile Hemangiomas: Short-Term Adverse Effects and Follow-Up to Age Two

OBJECTIVE: To analyse the short-term adverse effects (AEs) of propranolol in the treatment of infantile hemangiomas (IHs) and their relevant factors, as well as the relationship between child growth and propranolol. METHODS: A total of 506 patients with confirmed or suspected IHs were enrolled, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xueqing, Yang, Kun, Li, Hongwen, Huo, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899275/
https://www.ncbi.nlm.nih.gov/pubmed/31886190
http://dx.doi.org/10.1155/2019/2728952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899275/
https://www.ncbi.nlm.nih.gov/pubmed/31886190
http://dx.doi.org/10.1155/2019/2728952

Ejemplares similares